California's Cancer Burden
Cancer Disparities: Childhood Cancer
Across California, among children zero to 19 years of age, overall cancer incidence rates decreased an average of 0.7 percent per year from 2013 to 2022. Of the childhood cancers, the AAPC in the AAIR for central nervous system (CNS) tumors and retinoblastomas decreased significantly by six percent and 5.9 percent per year, respectively. Among adolescents and young adults (AYA), 15 to 39 years of age, overall cancer incidence rates increased an average of 0.6 percent per year from 2013 to 2022.
This table presents the incidence rates and counts of International Classification for Childhood Cancer (ICCC) groups among children zero to 19 years of age. In the last decade close to 1,800 children and young adults under the age of 20 were diagnosed with cancer each year. Among these, 67 percent are between zero to 14 years of age. The top three most common types of cancer diagnosed in children under the age of one are leukemias, followed by neuroblastoma, and CNS tumors. Leukemia is the most diagnosed cancer among children between one and 14 years of age, followed by CNS tumors, and lymphomas. Among children and young adults between 15 and 19 years of age, the top three most diagnosed cancers are other malignant epithelial neoplasms and melanomas, followed by lymphomas, and leukemias.
(Table 5: Childhood Cancer Rates by ICCC group)
Childhood Cancer Data Table
| | <1 year
| 1-14 years | 15-19 years | |
| Cancer ICCC Group* | Rate | Count | Rate | Count | Rate | Count | |
| All Cancer Types | 216.3 | 181 | 153.1 | 2,040 | 252.8 | 1,289 | |
| I. Leukemias, myeloproliferative & myelodysplastic diseases | 47.9 | 847 | 56.6 | 14,027 | 36.6 | 3,156 | |
| Lymphoid leukemias | 20.6 | 365 | 46.0 | 11,411 | 21.1 | 1,822 | |
| Acute myeloid leukemias | 18.0 | 319 | 7.6 | 1,878 | 9.5 | 824 | |
| II. Lymphomas and reticuloendothelial neoplasms | 13.4 | 237 | 17.9 | 4,346 | 45.5 | 3,932 | |
| Hodgkin lymphomas | ^ | ^ | 5.8 | 1,408 | 27.6 | 2,383 | |
| Non-Hodgkin lymphomas (except Burkitt lymphoma) | 1.6 | 28 | 7.1 | 1,715 | 14.7 | 1,265 | |
| III. CNS and misc. intracranial and intraspinal neoplasms | 28.9 | 511 | 28.4 | 6,973 | 18.4 | 1,587 | |
| Ependymomas and choroid plexus tumor | 4.5 | 79 | 2.6 | 650 | 1.4 | 119 | |
| Astrocytomas | 10.2 | 180 | 13.9 | 3,417 | 10.5 | 904 | |
| Intracranial and intraspinal embryonal tumors | 10.3 | 183 | 6.7 | 1,655 | 2.7 | 237 | |
| Other gliomas | 2.8 | 49 | 4.4 | 1,065 | 3.0 | 258 | |
| IV. Neuroblastoma and other peripheral nervous cell tumors | 43.8 | 774 | 6.6 | 1,674 | 0.8 | 70 | |
| V. Retinoblastoma | 25.8 | 456 | 2.8 | 703 | ^ | ^ | |
| VI. Renal tumors | 13.9 | 245 | 7.0 | 1,766 | 1.3 | 114 | |
| VII. Hepatic tumors | 11.9 | 211 | 2.0 | 515 | 1.3 | 112 | |
| VIII. Malignant bone tumors | 0.8 | 15 | 7.4 | 1,793 | 14.5 | 1,251 | |
| Osteosarcomas | ^ | ^ | 4.5 | 1,087 | 8.8 | 760 | |
| Ewing tumor and related sarcomas of bone | ^ | ^ | 2.3 | 559 | 3.8 | 332 | |
| IX. Soft tissue and other extraosseous sarcomas | 15.1 | 267 | 9.7 | 2,375 | 16.8 | 1,448 | |
| Rhabdomyosarcomas | 4.8 | 85 | 4.8 | 1,195 | 3.5 | 306 | |
| Fibrosarcomas, peripheral nerve & other fibrous | 4.0 | 70 | 0.7 | 167 | 2.1 | 183 | |
| X. Germ cell & trophoblastic tumors & neoplasms of gonads | 20.0 | 354 | 5.4 | 1,312 | 33.0 | 2,847 | |
| Extracranial & extragonadal germ cell tumors | 12.8 | 227 | 0.6 | 146 | 2.3 | 200 | |
| Malignant gonadal germ cell tumors | 4.8 | 85 | 2.8 | 676 | 25.6 | 2,212 | |
| XI. Other malignant epithelial neoplasms and melanomas | 1.6 | 29 | 7.3 | 1,768 | 47.2 | 4,078 | |
| XII. Other and unspecified malignant neoplasms | 1.5 | 26 | 0.4 | 98 | 1.1 | 92 | |
Rates are per 1,000,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard. * International Classification of Childhood Cancer (http://seer.cancer.gov/iccc/iccc-who2008.html). Number Count suppressed due to fewer than five cases. ^ Statistic not displayed due to fewer than 11 cases. Data Source: California Cancer Registry, California Department of Public Health.
|